AP - Anatomy and Pathology.Oncology
BI - Biochemistry.Molecular Biology
CL - Clinical.Epidemiologic Research
CO - Cornea
EY - Eye Movements.Strabismus.Amblyopia.Neuro-Ophthalmology
GEN - Genetics Cross-Sectional Group
GL - Glaucoma
IM - Immunology.Microbiology
LE - Lens
LV - Low Vision Cross-Sectional Group
MOI - Multidisciplinary Ophthalmic Imaging Cross-Sectional Group
NO ORGANIZING SECTION - Symposia
PH – Physiology.Pharmacology
RC - Retinal Cell Biology
RE - Retina
VI - Visual Psychophysics.Physiological Optics
VN - Visual Neuroscience

AP - Anatomy and Pathology Oncology

• Session 151 Retinoblastoma: From genetics and pathology to therapy
• Session 161 Posterior segment mechanisms and functions in eye development and myopia
• Session 215 Novel imaging and biomarkers for ocular tumors and disease
• Session 239 Embryology and morphogenesis of ocular structures
• Session 240 Optic and extraocular anatomy and function
• Session 242 Retinoblastoma: Basic/translational
• Session 243 Tumors - Inside and around the eye, I
• Session 310 Uveal melanoma: From clinical trials to molecular mechanisms
• Session 317 Visual functions, optical cues effecting and affected by myopia
• Session 334 Factors affecting ocular development
• Session 346 Retinoblastoma: Clinical
• Session 347 Tumors: Inside and around the eye, II
• Session 420 Molecular mechanisms in uveal melanoma
• Session 442 Uveal melanoma clinical studies
• Session 443 Physiological and myopic ocular biometry
• Session 478 Visual functions and processes conserved across species - Minisymposium
• Session 518 Factors mediating myopia
• Session 519 High myopia, associated complications and potential treatments
• Session 535 Novel findings and approaches in myopia research

 BI - Biochemistry.Molecular Biology

• Session 136 Structural/functional genomics and gene variants
• Session 137 Biochemistry and molecular biology of the retina
• Session 144 Biochemistry and Molecular Biology of AMD I
• Session 213 Genotype-phenotype correlations, prevalence studies and novel gene defects
• Session 226 Gene therapies
• Session 271 Molecular and biochemical mechanisms in retinal disorders
• Session 325 ER stress and the unfolded protein response in ocular health and disease - Minisymposium
• Session 376 Ocular gene expression, proteomics and lipidomics
• Session 377 Visual cycle and phototransduction
• Session 378 Cellular mechanisms of retinal diseases and ocular therapeutics
• Session 445 Gene editing and gene therapies
• Session 476 Ocular Transcriptomics and proteomics
• Session 483 Glaucoma: Biochemical and molecular disease mechanisms
• Session 507 Molecular mechanisms of diabetic retinopathy
• Session 508 Biochemistry and molecular biology of AMD II
• Session 533 Biochemistry and Molecular Biology implicated in diabetic retinopathy and glaucoma

CL - Clinical.Epidemiologic Research

•  Session 108 Genetic Epidemiology
• Session 148 Frequency of visual impairment and eye disease and their risk factors
• Session 211 Genetic Epidemiology
• Session 218 Living with vision loss
• Session 222 Retinal Diseases
• Session 223 AMD
• Session 233 Improving eye care delivery
• Session 278 Visual impairment
• Session 286 Refractive error
• Session 287 Pediatric eye disease
• Session 321 Diabetic eye disease
• Session 331 Understanding the course and risk factors for age-related macular degeneration
• Session 369 Refractive error: Risk factors to intervention studies
• Session 384 Glaucoma
• Session 410 Vision and driving: Lessons learned and future directions - Minisymposium
• Session 436 Improving care for Diabetic Retinopathy
• Session 479 Cornea and anterior chamber
• Session 488 Eye care delivery and economic research
• Session 531 Glaucoma: Frequency, risk factors, and care
• Session 539 Cataract/reporting of research
• Session 548 Ocular trauma

CO - Cornea

•  Session 103 Cornea wound healing and repair
• Session 133 Dry eye, non-clinical
• Session 142 Dry eye I
• Session 155 Cornea development
• Session 156 Corneal neovascularization, immunology and neuropathy
• Session 203 Corneal wound healing
• Session 220 Corneal biology and regenerative medicine
• Session 221 Corneal endothelium
• Session 225 Barrier function of the ocular surface - Minisymposium
• Session 263 Corneal development and repair
• Session 273 Corneal immunology and neuropathy
• Session 280 Lacrimal glands and Meibomian glands
• Session 301 Corneal imaging and biomechanics
• Session 314 Corneal epithelium
• Session 315 Dry eye, clinical 
• Session 324 Corneal dystrophies: Where do we stand? - Minisymposium
• Session 337 Contact lenses
• Session 362 Corneal tissue engineering and molecular biology
• Session 375 Corneal imaging, topography, and keratoconus
• Session 402 Dry eye II
• Session 409 Corneal endothelium and Fuchs' corneal dystrophy
• Session 418 Corneal stroma and keratocytes
• Session 419 Ocular surface health and disease
• Session 429 Corneal epithelium in health and disease
• Session 440 Corneal biomechanics
• Session 441 Conjunctival cell biol and Meibomian glands
• Session 468 Conjunctiva, Lacrimal and Meibomian glands and contact lenses
• Session 477 Corneal Surgery: Techniques and outcomes
• Session 509 Corneal refractive surgery
• Session 524 Keratoconus: Basic science and clinical applications
• Session 538 Corneal non-refractive surgery

 EY - Eye Movements.Strabismus.Amblyopia.Neuro-Ophthalmology

• Session 140 Eye movements
• Session 152 Nystagmus and gaze holding
• Session 236 Optical coherence tomography in pediatric neuro-ophthalmology - Minisymposium
• Session 285 Amblyopia I
• Session 322 Strabismus
• Session 345 Papilledema, IIH and optic nerve
• Session 372 Strabismus: Basic and clinical
• Session 414 Ambylopia II
• Session 415 Oculoplastics
• Session 416 Optic neuropathy
• Session 439 Intracranial hypertension and optic nerve changes
• Session 489 Pupil
• Session 503 Neurodegenerative diseases and brain trauma
• Session 504 Orbital and thyroid eye disease
• Session 536 Retinal abnormalities and neuropathology

 GEN - Genetics Cross-Sectional Group

• Session 245 Genetics of macular degeneration
• Session 276 Genetics of glaucoma
• Session 318 Whole genome analysis, genetic screening in retinal dystrophies and others
• Session 370 New insights and animal models
• Session 413 New genes and loci
• Session 446 Genetics of retinal dystrophies and functional analysis
• Session 527 Novel methods and mechanisms of disease
• Session 537 Genetics of corneal dystrophies

 GL - Glaucoma

•  Session 139 Imaging: Macula retina, blood flow, OCT angiography
• Session 150 Pharmacology and cellular mechanisms 
• Session 206 Optic nerve regeneration: Barriers past and future - Minisymposium
• Session 228 Imaging posterior segment and progression
• Session 230 IOP Measurement and characterization I
• Session 266 Neurodegeneration
• Session 274 Imaging: Anterior segment
• Session 275 Clinical trials and drug studies I
• Session 303 Biomechanics I
• Session 304 Clinical trials and drug studies II
• Session 312 Neurodegeneration and neuroprotection
• Session 320 Visual fields, vision function, psychophysics I
• Session 327 Neuroprotection
• Session 340 Biomechanics II
• Session 365 Capillaries, blood flow, OCT angiography
• Session 374 Trabecular meshwork and ciliary body
• Session 405 Trabecular meshwork, ciliary body and anterior segment imaging
• Session 421 Imaging: Optic nerve head and nerve fiber layer
• Session 432 Structure-function relationships I
• Session 449 Pharmacological intervention and cellular mechanisms
• Session 471 Visual fields, vision function, psychophysics II
• Session 484 Surgery and wound healing
• Session 485 Laser therapy and MIGS
• Session 511 IOP measurement and characterization II
• Session 526 Surgery, laser therapy, wound healing
• Session 543 Structure-Function Relationships II
• Session 544 Electrophysiology

IM - Immunology.Microbiology

•  Session 134 Uveitis therapeutics: Remedy and relief
• Session 135 Autoimmune ocular disease: selfies gone wrong
• Session 149 Systemic influences on ocular disease
• Session 212 Emerging treatments for uveitis
• Session 234 Immunological influences on AMD
• Session 277 Uveitis: Diagnosis, epidemiology, quality of life
• Session 332 Going viral!\
• Session 379 Clinical virology
• Session 380 Mechanisms of viral infections
• Session 411 All of the eye is a stage and immune cells are merely players - Minisymposium
• Session 417 Clinical microbiology
• Session 437 Basic investigations in the treatment of ocular infections
• Session 475 The bench and the bedside: Who is the instructor? - Minisymposium
• Session 532 Genomics and proteomics to dissect normal and diseased ocular sites: an immunology and microbiology perspective
• Session 540 Immune mechanisms in eye disease: Perception and reality
• Session 541 Infection and immunology

LE - Lens

• Session 141 Cataract surgery outcomes and epidemiology
• Session 147 Genetics and modeling of lens and anterior segment anomalie - Minisymposium
• Session 163 Cataract surgery - IOLs
• Session 209 Lens development and cell biology
• Session 238 Lens development and molecular cell biology
• Session 244 Cataract surgery procedures
• Session 269 Cataractogenesis I
• Session 306 Lens physiology and biomechanics I
• Session 341 Cataractogenesis II
• Session 381 Lens physiology and biomechanics II
• Session 408 Lens epithelial cells and PCO
• Session 434 Membrane domains: Polarity, trafficking and assembly in the eye - Minisymposium
• Session 510 Crystallins
• Session 529 Lens biochemistry

LV - Low Vision Cross-Sectional Group

• Session 270 Impact of low vision on mobility
• Session 307 Impact of low vision on function and everyday activities
• Session 344 Functioning with low vision
• Session 452 Low vision populations, services and treatments
• Session 474 Low vision devices and rehabilitation
  

MOI - Multidisciplinary Ophthalmic Imaging Cross-Sectional Group

• Session 112 Adaptive optics ophthalmoscopy: technology and application
• Session 138 Image processing and interpretation
• Session 146 Deep learning for image segmentation and classification
• Session 217 OCT applications
• Session 237 Clinical applications of OCT angiography
• Session 264 Biomarkers based on vasculature Imaging
• Session 338 Functional imaging
• Session 339 Innovations in imaging
• Session 412 Novel ophthalmic instrumentation and imaging
• Session 480 Imaging technology and applications
• Session 481 Animal imaging
• Session 516 Advancements in OCT
• Session 517 Wide field retinal imaging

NO ORGANIZING SECTION - Symposia

• Session 101 Light-based treatment strategies for blinding eye disease
• Session 102 Homologies between the brain and the eye: Can ocular researchers lead the way or are we following our 'brainy' colleagues?
• Session 164 Improving global eye health: Beating the odds for neglected and emerging diseases around the world
• Session 501 Genes and disease: How knowledge of genetics can guide treatment, now and in the future
• Session 502 The global problem of antibiotic resistance: Impact on ocular health worldwide and researching alternatives

PH – Physiology.Pharmacology

• Session 109 Cytokines; growth factors; Antiangiogenic drugs
• Session 110 Retina;RPE; Mechanisms
• Session 159 Intraocular pressure; aqueous humor dynamics
• Session 160 Anti-inflammatory; antibiotics; antivirals
• Session 208 Retina/RPE 1
• Session 249 AMD: New drugs, delivery systems
• Session 268 Retina
• Session 329 Retina/RPE 2
• Session 336 Blood flow
• Session 367 Intraocular pressure
• Session 407 Inflammaging and eye - Minisymposium
• Session 424 Drug and gene therapy and delivery
• Session 444 Drug delivery I
• Session 473 Drug delivery II
• Session 505 Toxicology; hypoxia; ischemia; oxidative stress; corneal disease
• Session 528 Molecular pharmacology and ocular toxicology
• Session 542 Diabetic retinopathy

RC - Retinal Cell Biology

• Session 106 Development of the retina
• Session 111 Retinal degeneration. Models and mechanisms
• Session 130 Determinants of PR development and repair
• Session 143 Retinal glia
• Session 158 New insights in RPE anatomy and physiology
• Session 204 Common pathogenic role of inflammation in retinal diseases - Minisymposium
• Session 219 Stem cells for ganglion cell regeneration and repair
• Session 231 RPE metabolism, autophagy and cell death
• Session 241 Ganglion Cells: Development, axotomy, trauma
• Session 250 AMD-novel therapies
• Session 281 Bruch's membrane and choroid in macular disease
• Session 282 RPE dysfunction in macular diseases
• Session 302 Angiogenesis
• Session 308 Photoreceptors: Cell biology, disease and rescue
• Session 311 Diabetic retinopathy: Basic mechanisms
• Session 335 Cellular metabolism of the retina and RPE
• Session 363 Macular degeneration-cell biology
• Session 373 ROP: Basic mechanisms 
• Session 403 Stem cells: New approaches and disease modeling 
• Session 422 Diabetic retinopathy: New targets and emerging therapies
• Session 423 Angiogenesis: Basic mechanisms
• Session 430 Diabetic retinopathy
• Session 447 Photoreceptor degeneration and retinal rescue strategies
• Session 448 Stem cells and tissue engineering for retinal repair
• Session 469 An eye on the eye microvasculature - Minisymposium
• Session 506 Diabetic retinopathy: Neurodegeneration and pathology associated with the neurovascular unit.
• Session 513 Oxidative damage, ER stress and autophagy
• Session 514 Non-neural cells of the retina: Glia and microglia
• Session 525 Cellular and molecular bases of retinal development
• Session 546 Paradigms of retinal degeneration and rescue

RE - Retina

• Session 104 AMD imaging 1
• Session 105 Diabetic retinopathy: medical (non-surgical)
• Session 131 AMD imaging 2
• Session 132 AMD and anti-VEGF therapy 1
• Session 145 OCT angiography in AMD
• Session 153 AMD and anti-VEGF therapy 2
• Session 154 Diabetic macular edema clinical research
• Session 205 Vitreoretinal surgery I
• Session 207 AMD and anti-VEGF therapy
• Session 224 Retinal vascular diseases I (excluding diabetes)
• Session 227 AMD imaging I
• Session 229 Vitreoretinal interface and retinal detachment
• Session 246 Clinical retinal imaging 1
• Session 247 Diabetic macular edema and anti-VEGF therapy
• Session 248 AMD therapies (excluding anti-VEGF)
• Session 265 Inherited retinal diseases and mactel
• Session 267 Diabetic macular edema clinical and anti-VEGF research
• Session 283 AMD translational studies and choroidal neovascularization
• Session 284 AMD Clinical Research 1
• Session 305 Novel therapies and imaging techniques for retinal disorders - Minisymposium
• Session 319 Vitreoretinal surgery
• Session 326 Diabetic retinopathy clinical
• Session 328 Retinal vascular diseases and CSCR
• Session 342 AMD Clinical Research 2
• Session 343 Retinitis pigmentosa (clinical)
• Session 364 Retinal gene therapy and stem cell transplantation
• Session 366 AMD imaging II and visual function
• Session 382 Retinal vascular diseases II (excluding diabetes)
• Session 383 Macular diseases (non-inherited)
• Session 404 AMD clinical research
• Session 406 Diabetic retinal imaging
• Session 426 Retinal detachment (clinical)
• Session 427 Retinal prostheses
• Session 431 Vitreoretinal surgery II and endophthalmitis
• Session 433 Retinal prostheses
• Session 450 Macular edema clinical and translational
• Session 451 Macular diseases (inherited)
• Session 470 Retinopathy of prematurity
• Session 472 Clinical posterior segment imaging
• Session 486 Vitreoretinal surgery novel approaches and vitreoretinal interface
• Session 487 Diabetic retinopathy clinical and surgical
• Session 520 Endophthalmitis and trauma
• Session 521 Retinopathy of prematurity
• Session 547 Myopic CNV and CSCR
• Session 549 Retinal detachment: Basic research
• Session 550 Clinical retinal imaging 2 and lasers

VI - Visual Psychophysics.Physiological Optics

• Session 113 Accommodation and presbyopia correction
• Session 162 Aberrations, optical models
• Session 214 IOL and presbyopia correction
• Session 216 AO, OCT, and advanced optical methods
• Session 235 Applications of adaptive optics for retinal imaging and visual function testing - Minisymposium
• Session 272 Mechanisms of accommodation
• Session 309 Surprising human visual processes revealed with advanced techniques
• Session 316 Anterior segment imaging and optics
• Session 333 Age-related changes in optics of the eye and vision - Minisymposium
• Session 371 Improving Retinal Imaging and Image Understanding- AO
• Session 428 Spatial and temporal vision
• Session 438 Color vision, low vision
• Session 453 VI Poster 7: Vision in aging and disease
• Session 515 Color vision, binocular and stereoscopic vision
• Session 534 Visual perception with defocus, distortions, and training

VN - Visual Neuroscience

• Session 157 Outer retina function
• Session 210 Diseases and protection
• Session 232 Ganglion cells
• Session 279 Inner retinal circuits
• Session 313 Ganglion cells and beyond
• Session 330 Bipolar, horizontal and amacrine cells
• Session 368 Beyond the retina: Central visual circuits - Minisymposium
• Session 425 ipRGCs and Circadian Rhythms
• Session 435 ERG: Advances, disease and injury
• Session 482 Clinical electrophysiology
• Session 512 Retinal function: ERG studies
• Session 530 Photoreceptors
• Session 545 Visual disease models and restoration